Toronto, Ontario–(Newsfile Corp. – April 26, 2021) – Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) (“Relay” or the “Company“), a technology developer and innovator, announces that Emerging Markets Consulting, LLC (EMC) has been retained to provide investor and public relations services. EMC specializes in helping small and mid-sized public companies establish brand awareness and increase market share to its customer base while improving visibility to the institutional and retail investment community.
“With the recent deployments of Toronto Airport and partnering with Canada’s largest lab company Lifelabs, Relay has a lot to share with the marketplace,” said W. Clark Kent, President, Relay Medical Corp. “We look forward to working with Emerging Markets to bring Relay to a broader audience and build on our communication as we progress through these milestones and others like the recent acquisition of Cybeats, an innovative IoT Cybersecurity company.”
James Painter, President of EMC, said, “with the termotulous year we have all faced, hope springs eternal. Working with Relay Medical is an honor and a privilege. The company’s prospects met our stringent requirements and we are happy to have Relay on our prestigious client roster.”
The Company announces that it has granted an aggregate of 1,500,000 options to purchase common shares of the Company at $0.50 per common share and expiring five (5) years from the date of grant, to certain officers, directors and consultants of the Company.
About Emerging Markets Consulting LLC
Based in Orlando, Florida, Emerging Markets Consulting, LLC (EMC) brings over 40 years combined experience in the investor relations industry. EMC is an international investor relations firm with affiliates around the world. EMC is relationship-driven and results-oriented with the goal of seeking attractive emerging companies and concentrating its resources and efforts to serve a limited number of high-quality clients.
For more information, visit EMC’s website at www.emergingmarketsllc.com
About Relay Medical Corp.
Relay Medical is a technology innovation Company headquartered in Toronto, Canada focused on the development of novel technologies in the diagnostics and AI data science and IoT security sectors.
For Media Inquiries, please contact: Destine Lee [email protected] | 647-872-9982
SUBSCRIBE: For more information on Relay or to subscribe to the Company’s mail list visit: https://www.relaymedical.com/news
W. Clark Kent
Relay Medical Corp.
Office. 647-872-9982 ext. 3
TF. 1-844-247-6633 ext. 3
EU Investor Relations
Office. +49 (0) 177 774 2314
Email: [email protected]
Forward-looking Information Cautionary Statement
Except for statements of historic fact, this news release contains certain “forward-looking information” within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as “plan”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate” and other similar words, or statements that certain events or conditions “may” or “will” occur. Forward-looking statements are based on the opinions and estimates at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including, but not limited to delays or uncertainties with regulatory approvals, including that of the CSE. There are uncertainties inherent in forward-looking information, including factors beyond the Company’s control. There are no assurances that the commercialization plans for the technology described in this news release will come into effect on the terms or time frame described herein. The Company undertakes no obligation to update forward-looking information if circumstances or management’s estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Additional information identifying risks and uncertainties that could affect financial results is contained in the Company’s filings with Canadian securities regulators, which filings are available at www.sedar.com.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/81761
Powered by WPeMatico